Legal & General Group
IPSC icon

Legal & General Group’s Century Therapeutics IPSC Stock Holding History

Legal & General Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+43,960
New +$100K ﹤0.01% 2633
2025
Q2 		– Sell
-3,976
Closed -$1.89K – 3474
2025
Q1 		$1.89K Hold
3,976
– – ﹤0.01% 3357
2024
Q4 		$4.02K Hold
3,976
– – ﹤0.01% 3356
2024
Q3 		$6.78K Hold
3,976
– – ﹤0.01% 3342
2024
Q2 		$10.1K Buy
3,976
+1,863
+88% +$5.89K ﹤0.01% 3294
2024
Q1 		$8.83K Hold
2,113
– – ﹤0.01% 3226
2023
Q4 		$7K Hold
2,113
– – ﹤0.01% 3283
2023
Q3 		$4.23K Hold
2,113
– – ﹤0.01% 3372
2023
Q2 		$6.68K Hold
2,113
– – ﹤0.01% 3360
2023
Q1 		$7.33K Hold
2,113
– – ﹤0.01% 3253
2022
Q4 		$10.8K Buy
2,113
+414
+24% +$3.91K ﹤0.01% 3254
2022
Q3 		$17K Sell
1,699
-291
-15% -$3.06K ﹤0.01% 3245
2022
Q2 		$17K Buy
1,990
+330
+20% +$3.24K ﹤0.01% 3292
2022
Q1 		$21K Buy
1,660
+555
+50% +$7.35K ﹤0.01% 3232
2021
Q4 		$17K Hold
1,105
– – ﹤0.01% 3325
2021
Q3 		$28K Buy
1,105
+105
+11% +$2.84K ﹤0.01% 3151
2021
Q2 		$29K Buy
+1,000
New +$25.4K ﹤0.01% 3146

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Legal & General Group's IPSC Position: Q2 2026 in Review

Legal & General Group opened a new position in Century Therapeutics (IPSC) in Q2 2026: 43,960 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #2633 among its holdings. This is a return to the name: Legal & General Group previously reported a position in IPSC as recently as Q1 2025.

Legal & General Group first reported a position in IPSC in Q2 2021 and has held it in 17 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Legal & General Group held 43,960 shares of Century Therapeutics worth $108K as of Q2 2026.
  • Century Therapeutics was a new Legal & General Group position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2633 holding.
  • Legal & General Group first reported a position in Century Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.